← Leaderboards
Vikas Vasudeo Dukhande
St. John'S University
$1,148,000
Attributed
$1,148,000
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $164K · FY2018–25$200K$150K$100K$50K$0
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,148,000 · 2
By mechanism
R16$656,000 · 1
SC2$492,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Grant”
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$208,271,537
- Kimberly Smith · Ppd Development Lp$115,671,664
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Peter W Pisters · University Of Tx Md Anderson Can Ctr$76,895,673
- Julie Brisset · The University Of Central Florida Board Of Trustees$41,275,036
- Nancy Roche · Leidos Biomedical Research, Inc.$39,999,252
Research focus
GrantBrainProtein ExpressionPharmacotherapyProteinsMetabolicGlycogenLinkMetabolic Abnormality AssessmentPharmacologyResistanceSignal TransductionPathway InteractionsMutationCellsEpilepsyGlycogen PhosphorylaseHealthcareBiological AvailabilityBiologicalAnalog-Amp-Activated Protein KinaseCancer CellAntioxidants
Grant awards (7)
Pharmacological and Chemical Approaches to Repurpose an Antiepileptic for Glioblastoma Treatment$164,000
R16 · FY2025 · GM · contact PI
Pharmacological and Chemical Approaches to Repurpose an Antiepileptic for Glioblastoma Treatment$164,000
R16 · FY2024 · GM · contact PI
Pharmacological and Chemical Approaches to Repurpose an Antiepileptic for Glioblastoma Treatment$164,000
R16 · FY2023 · GM · contact PI
Pharmacological and Chemical Approaches to Repurpose an Antiepileptic for Glioblastoma Treatment$164,000
R16 · FY2022 · GM · contact PI
Clues from a rare neurodegenerative disease towards target identification for diabetes mellitus$164,000
SC2 · FY2020 · GM · contact PI
Clues from a rare neurodegenerative disease towards target identification for diabetes mellitus$164,000
SC2 · FY2019 · GM · contact PI
Clues from a rare neurodegenerative disease towards target identification for diabetes mellitus$164,000
SC2 · FY2018 · GM · contact PI